DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Metabolic EnzymesMetabolic Enzymes
  5. /FXRFXR
  6. /Bms-986318Bms-986318
Chemical structure of CAS 2314378-09-9

Bms-986318

CAS No.2314378-09-9
MDL No.N/A
MFC30H23Cl2F3N4O3
MW615.40
InChI KeyWPGAVSDZYIRUGE-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2314378-09-9
Product NameBms-986318
Heavy Atom Count42Rotatable Bond Count5
Atom Stereo Count0Bond Stereo Count0
HBA6HBD1
TPSA92.350 ŲCharge0
Exact Mass614.10993Complexity1770.36
pKa0.577XLogP8.260

Related Articles

Studies related to this compound and its mechanism of action

Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis.

ACS medicinal chemistry letters • Vol. 12, Issue 9 • 2021
PMID: 34531950PMC: PMC8436248DOI: 10.1021/acsmedchemlett.1c00198

Documentation

Similar Products

  • (+)-Vincristine

    CAS No.132142-73-5

  • Vincristine Sulfate

    CAS No.2068-78-2

  • Vinorelbine

    CAS No.71486-22-1

  • Navelbine ditartrate (TN)

    CAS No.125317-39-7

  • Vinblastine

    CAS No.865-21-4

  • Vinblastine Sulfate

    CAS No.143-67-9

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact